Late resistance to adenoviral p53-mediated apoptosis caused by decreased expression of Coxsackie-adenovirus receptors in human lung cancer cells

Cancer Science

Volumn 95, Issue 5, 2004, Pages 459-463

  Tango, Yasuhisa ^a   Taki, Masaki ^b   Shirakiya, Yoshiko ^b   Ohtani, Shoichiro ^b   Tokunaga, Naoyuki ^b   Tsunemitsu, Yosuke ^b   Kagawa, Shunsuke ^b,c   Tani, Toru ^a   Tanaka, Noriaki ^b   Fujiwara, Toshiyoshi ^b,c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD51 ANTIGEN; CELL RECEPTOR; COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CANCER THERAPY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DOSE REGIMEN; DRUG RESISTANCE; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INTERNALIZATION; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; VIRAL GENE THERAPY; VIRUS ADSORPTION; VIRUS INFECTION;

ADENOVIRIDAE INFECTIONS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; COXSACKIEVIRUS INFECTIONS; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; HUMANS; IMMUNITY, NATURAL; LUNG NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 3042635823     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03232.x     Document Type: Article

References (33)

1. Merritt JA, Roth JA, Logothetis CJ. Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies. Semin Oncol 2001; 28: 105-14.
2. Svensson U, Oersson R, Everitt E. Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of HeLa cell plasma membrane. J Virol 1981; 38: 70-81.
3. Devaux C, Caillet-Boudin ML, Jarcot B, Boulanger P. Crystallization, enzymatic cleavage, and the polarity of the adenovirus type 2 fiber. Virology 1987; 161: 121-8.
4. Greber UF, Willetts M, Webster P, Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993; 75: 477-86.
5. Louise N, Fender P, Barge A, Kitts P, Chroboczek J. Cell-binding domain of adenovirus serotype 2 fiber. J Virol 1994; 68: 4104-6.
6. Bai M, Harfe B, Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol 1993; 67: 5198-205.
7. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-19.
8. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994; 127: 257-64.
9. Dechecchi MC, Tamanini A, Bonizzaato A, Cabrini G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000; 268: 382-90.
10. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-3.
11. Bergelson JM, Krithivas A, Celli L, Droguett G, Horwitz MS, Wickham T, Crowell RL, Finberg RW. The murine CAR homolog is a receptor for coxsackie B virused and adenoviruses. J Virol 1998; 72: 415-9.
12. Maxwell SA, Davis GE. Biological and molecular characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis. Apoptosis 2000; 5: 277-90.
13. Maxwell SA, Davis GE. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA 2000; 97: 13009-14.
14. Yamamoto S, Yoshida Y, Aoyagi M, Ohno K, Hirakawa K, Hamada H. Reduced transduction efficiency of adenoviral vectors expressing human p53 gene by repeated transduction into glioma cells in vitro. Clin Cancer Res 2002; 8: 913-21.
15. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287-91.
16. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. High-efficacy gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994; 1: 5-13.
17. CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene 1997; 15: 1903-9.
18. Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system in apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene 1999; 18: 2189-99.
19. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 812-25.
20. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-16.
21. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000; 404: 24-5.
22. Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12: 461-8.
23. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053-8.
24. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y. p53AIP1, a potent mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-62.
25. Thornborrow EC, Manfredi JJ. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J Biol Chem 1999; 274: 33747-56.
26. You Z, Fischer CD, Tong X, Hasenburg A, Aguilar-Cordova E, Kieback GD. Coxsackie virus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression. Cancer Gene Ther 2001; 8: 168-75.
27. Mizuguchi H, Koizumi N, Hosono T, Ishii-Watanabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T. CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther 2002; 9: 769-76.
28. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, Hsieh JT. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325-30.
29. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000; 60: 5031-6.
30. Koizumi N, Mizuguchi H, Hosono T, Ishii-Watanabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim Biophys Acta 2001; 1568: 13-20.
31. Wu H, Seki T, Dmitriev I, Uil T, Kashentseva E, Han T, Curiel DT. Double modification of adenovirus fiber with RGD and polylysine motif improves coxsackie virus-adenovirus receptor-independent gene transfer efficiency. Hum Gene Ther 2002; 13: 1647-53.
32. Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S, Tanaka N, Fujiwara T. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res 2004; 10: 285-92.
33. Mizuguchi H, Hayakawa T. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 2002; 285: 69-77.